Document is current
Any future updates will be listed below
-
Authors
Gustad, Lise Tuset http://orcid.org/0000-0003-2709-3991
Myklebust, Tor Åge http://orcid.org/0000-0003-4645-1635
Bjerkeset, Ottar http://orcid.org/0000-0002-9023-4980
Williams, Lana J. http://orcid.org/0000-0002-1377-1272
Laugsand, Lars Erik http://orcid.org/0000-0002-1756-9573
Dalen, Håvard http://orcid.org/0000-0003-1192-3663
Berk, Michael http://orcid.org/0000-0002-5554-6946
Romundstad, Solfrid http://orcid.org/0000-0001-8546-0791
-
Funding
Funding for this research was provided by:
the Central Norway Regional Health Authority (NA)
- License Information
-
More Information
Article History
Received: 31 August 2021
Accepted: 26 October 2022
First Online: 8 November 2022
Declarations
:
: Consent for publication is given by the data access committee for Nord-Trøndelag Hospital Trust and the HUNT Study on behalf of all participants.
: This study was approved by the Regional Committee for Medical and Health Research Ethics in South East Norway (2010/178–2/REC Mid-Norway) with the last extension for follow-up until end 2016 obtained in 2019 (ref no 12364). The study is also approved by the data access committees for Nord-Trøndelag Hospital Trust and the HUNT Study. The study followed the principles in the Declaration of Helsinki published by the World Medical Association, including a knowledge-based design, all methods were performed in accordance with the protocols, it was no consequences for not participating and participation in this study included no harm to the participant. Further, all participants in HUNT2 and HUNT3 gave written and informed consent for the use of their data in research, including linkage with hospital registries.
: MB has received Grant/Research Support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, Medical Benefits Fund, National Health and Medical Research Council, Medical Research Futures Fund, Beyond Blue, Rotary Health, A2 milk company, Meat and Livestock Board, Woolworths, Avant and the Harry Windsor Foundation, has been a speaker for Astra Zeneca, Lundbeck, Merck, Pfizer, and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Lundbeck Merck, Pfizer and Servier – all unrelated to this work. LJW has received Grant/Research support from Eli Lilly, Pfizer, The University of Melbourne, Deakin University and the NHMRC. LJW is supported by an NHMRC Career Development Fellowship (1064272) and a NHMRC Investigator grant (1174060). MB is supported by a NHMRC Senior Principal Research Fellowship (1059660 and 1156072). All competing interests are unrelated to this work.
